Metabolomics for hematologic malignancies: Advances and perspective

被引:0
|
作者
Li, Xinglan [1 ]
Xu, Mengyu [1 ]
Chen, Yanying [2 ]
Zhai, Yongqing [3 ]
Li, Junhong [1 ]
Zhang, Ning [4 ]
Yin, Jiawei [5 ,6 ,7 ]
Wang, Lijuan [5 ,6 ,7 ,8 ]
机构
[1] Shandong Second Med Univ, Linyi Peoples Hosp, Linyi, Peoples R China
[2] Linyi Peoples Hosp, Hematol Lab, Linyi, Peoples R China
[3] Linyi Peoples Hosp, Dept Orthoped, Linyi, Peoples R China
[4] Linyi Peoples Hosp, Dept Anesthesiol, Linyi, Peoples R China
[5] Linyi Peoples Hosp, Cent Lab, Linyi, Peoples R China
[6] Key Lab Tumor Biol, Linyi, Peoples R China
[7] Xuzhou Med Univ, Key Lab Translat Oncol, Xuzhou, Peoples R China
[8] Linyi Peoples Hosp, Dept Hematol, Linyi, Peoples R China
关键词
amino acid metabolism; glucose metabolism; leukemia; lipid metabolism; lymphoma; myeloma; ACUTE MYELOID-LEUKEMIA; B-CELL LYMPHOMA; METABOLISM; SERUM; MICROENVIRONMENT; CHROMATOGRAPHY; PROLIFERATION; BIOMARKERS; SIGNATURE; RESISTANT;
D O I
10.1097/MD.0000000000039782
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With the use of advanced technology, metabolomics allows for a thorough examination of metabolites and other small molecules found in biological specimens, blood, and tissues. In recent years, metabolomics has been recognized that is closely related to the development of malignancies in the hematological system. Alterations in metabolomic pathways and networks are important in the pathogenesis of hematologic malignancies and can also provide a theoretical basis for early diagnosis, efficacy evaluation, accurate staging, and individualized targeted therapy. In this review, we summarize the progress of metabolomics, including glucose metabolism, amino acid metabolism, and lipid metabolism in lymphoma, myeloma, and leukemia through specific mechanisms and pathways. The research of metabolomics gives a new insight and provides therapeutic targets for the treatment of patients with hematologic malignancies.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Hematologic Malignancies of the Breast
    Alsadi, Alaa
    Murro, Diana
    Martyn, Colin
    Miller, Ira
    Gattuso, Paolo
    LABORATORY INVESTIGATION, 2015, 95 : 33A - 33A
  • [32] Immunotherapy for Hematologic Malignancies
    Craddock, Charles
    Friedberg, Jonathan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (05) : 343 - +
  • [33] Telomerase in hematologic malignancies
    Bruedigam, Claudia
    Lane, Steven W.
    CURRENT OPINION IN HEMATOLOGY, 2016, 23 (04) : 346 - 353
  • [34] Immunotherapy in hematologic malignancies
    Kansara, R. R.
    Speziali, C.
    CURRENT ONCOLOGY, 2020, 27 : S124 - S131
  • [35] The Microbiota in Hematologic Malignancies
    Yajing Song
    Bryan Himmel
    Lars Öhrmalm
    Peter Gyarmati
    Current Treatment Options in Oncology, 2020, 21
  • [36] Angiogenesis in hematologic malignancies
    Moehler, TM
    Ho, AD
    Goldschmidt, H
    Barlogie, B
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 45 (03) : 227 - 244
  • [37] Hematologic malignancies of childhood
    Head, David R.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 : S7 - S7
  • [38] Epigenetics in the hematologic malignancies
    Fong, Chun Yew
    Morison, Jessica
    Dawson, Mark A.
    HAEMATOLOGICA, 2014, 99 (12) : 1772 - 1783
  • [39] Chromothripsis in hematologic malignancies
    Lagunas-Rangel, Francisco Alejandro
    EXPERIMENTAL HEMATOLOGY, 2024, 132
  • [40] Angiogenesis in hematologic malignancies
    Mesters, RM
    ANNALS OF HEMATOLOGY, 2002, 81 : S72 - S74